Showing results (161-170 of 275) with videos related to
Sort By:
Pageof 28
AIDS (London, England)|June 1, 1996
A controlled trial of nevirapine plus zidovudine versus zidovudine alone in p24 antigenaemic HIV-infected patients. The Dutch-Italian-Australian Nevirapine Study GroupA Carr, S Vella, M D de Jong, et al.AIDS (London, England)|November 5, 1999
The relationship between ritonavir plasma levels and side-effects: implications for therapeutic drug monitoringG Gatti, A Di Biagio, R Casazza, et al.AIDS (London, England)|January 1, 1995
Effect of sex, age and transmission category on the progression to AIDS and survival of zidovudine-treated symptomatic patientsS Vella, M Giuliano, M Floridia, et al.AIDS (London, England)|April 15, 1999
Thymus volume correlates with the progression of vertical HIV infectionA Vigano', S Vella, N Principi, et al.HIV Medicine|May 16, 2002
HIV-related morbidity and mortality in patients starting protease inhibitors in very advanced HIV disease (CD4 count of < 50 cells/microL): an analysis of 338 clinical events from a randomized clinical trialM Floridia, V Fragola, C M Galluzzo, et al.Proceedings of the National Academy of Sciences of the United States of America|March 14, 1995
Emergence of human immunodeficiency virus type 1 variants with resistance to multiple dideoxynucleosides in patients receiving therapy with dideoxynucleosidesT Shirasaka, M F Kavlick, T Ueno, et al.Annals of Internal Medicine|April 1, 1988
Treatment of the acquired immunodeficiency syndrome (AIDS) and AIDS-related complex with a regimen of 3'-azido-2',3'-dideoxythymidine (azidothymidine or zidovudine) and acyclovir. A pilot studyA Surbone, R Yarchoan, N McAtee, et al.Annals of Internal Medicine|August 15, 1990
Development of non-Hodgkin lymphoma in a cohort of patients with severe human immunodeficiency virus (HIV) infection on long-term antiretroviral therapyJ M Pluda, R Yarchoan, E S Jaffe, et al.Journal of the National Cancer Institute|May 15, 1991
Projections of the incidence of non-Hodgkin's lymphoma related to acquired immunodeficiency syndromeM H Gail, J M Pluda, C S Rabkin, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 1, 1995
Phase I/II study of intermittent all-trans-retinoic acid, alone and in combination with interferon alfa-2a, in patients with epidemic Kaposi's sarcomaJ Bailey, J M Pluda, A Foli, et al.Pageof 28